Navigation Links
Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program

ur revenues may be adversely affected.

Certain of our products have experienced manufacturing issues. If the issues recur and cannot be resolved, our ability to acquire product for sale and sampling will be adversely affected. We may incur unexpected costs in integrating new products into our operations.

We may be unable to develop or market line extensions for our products including Prenate, Sular, Triglide, Nitrolingual, Altoprev and Fortamet, or, even if developed, obtain patent protection for our line extensions; further, introductions by us of line extensions of our existing products may require that we make unexpected changes in our estimates for future product returns and reserves for obsolete inventory. If these risks occur, our financial results could be adversely affected.

If we have difficulties acquiring new products or rights to market new products from third parties, our financial results could be adversely impacted. Our licensor/supplier can terminate our rights to commercialize Nitrolingual and the 60 dose size of this product has not yet met our expectation.

We depend on a small senior management group, the departure of any member of which would likely adversely affect our business if a suitable replacement member could not be retained.

An adverse interpretation or ruling by one of the taxing jurisdictions in which we operate could adversely impact our operating results. An adverse judgment in the securities class action litigation in which we and certain current and former directors and executive officers are defendants could have a material adverse effect on our financial results and liquidity. Our business is subject to increasing government price controls and other healthcare cost containment measures. Side effects or marketing or manufacturing problems with our products could result in product liability claims which could be costly to defend and could result in the withdrawal or recall of products from the mar
'"/>




Page: 1 2 3 4

Related medicine technology :

1. SkyePharma and Sciele Pharma Announce Successful Completion of New Sular Formulation Clinical Trial Programme
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:6/2/2015)... 2015  BD (Becton, Dickinson and Company) (NYSE: ... company, today announced its participation in the White ... steps the company will take to help combat ... full range of expertise related to identification and ... information to electronic surveillance and prevention of health ...
(Date:6/2/2015)... 2015 Northstar Global Business Services, Inc. ... commercial advertisement, which it plans to use in ... company,s top selling product. The advertisement ... with television advertising. Previous ads focused on a ... version takes an entertainment-oriented path, and uses one ...
(Date:6/2/2015)... MADRID , June 2, 2015 /PRNewswire/ ... meeting annuale della American Society of Clinical Oncology    ... multicentrico di fase 3 SAR3007, resi noti dal dipartimento ... hanno evidenziato un significativo miglioramento della sopravvivenza libera da ... ) rispetto al trattamento con dacarbazina in pazienti con ...
Breaking Medicine Technology:BD Participates in White House Forum on Antibiotic Stewardship 2BD Participates in White House Forum on Antibiotic Stewardship 3Northstar releases its direct response multi-media ad designed to be used in national television advertising campaigns 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6
... 2011 Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader ... the year ended December 31, 2010. Financial ... Ended December 31, 2009: Total revenues were ... the U.S. decreased 16% to $4.53 million from $5.28 million. ...
... 4, 2011 MonoSol Rx, the developers of PharmFilm® ... pharmaceutical film products, today announced that it has been ... Patent and Trademark Office (USPTO). The patent provides intellectual ... preparation along with the incorporation of specific drugs and ...
Cached Medicine Technology:Milestone Scientific Announces 2010 Year End Results 2Milestone Scientific Announces 2010 Year End Results 3Milestone Scientific Announces 2010 Year End Results 4Milestone Scientific Announces 2010 Year End Results 5Milestone Scientific Announces 2010 Year End Results 6MonoSol Rx Issued Strategic US Patent Governing the Production of Pharmaceutical Films Containing Specific Drugs and Drug Classes 2MonoSol Rx Issued Strategic US Patent Governing the Production of Pharmaceutical Films Containing Specific Drugs and Drug Classes 3
(Date:6/2/2015)... June 02, 2015 CRN International has been ... Platform to Employment , a Connecticut state program that takes ... and place them at appropriate companies. , Platform to Employment ... with the Connecticut Department of Labor. CRN, a 40-year-old radio ... the program, is being recognized for its “hard work and ...
(Date:6/2/2015)... COLUMBIA, Md. (PRWEB) June 02, 2015 ... of its LCMS-8060 triple quadrupole mass spectrometer. The ... series, the LCMS-8060 combines Shimadzu’s proprietary ultrafast technologies ... unparalleled combination results in outstanding data quality and ... and routine applications. , The LCMS-8060 features new ...
(Date:6/2/2015)... Zambia (PRWEB) June 02, 2015 ... businesses, today opened a new seed warehouse and office ... and meet farmer demand for both local and export ... , “Zambia could emerge as the breadbasket for ... said Worede Woldemariam, East and South Central Africa senior ...
(Date:6/2/2015)... 2015 PhishLine, LLC today announced ... Swenson Drive, Suite 125 in Waukesha, Wisconsin 53186. ... new base of operations for PhishLine’s current corporate ... growth. , Mark Chapman, Founder and President, commented ... as enterprise customers adopt our market leading service ...
(Date:6/2/2015)... a popular online store selling celebrity inspired fashion products, ... dresses. The company carries more than 1000 styles of ... a wide variety of summer events like wedding and ... quality trendy special occasion dresses and accessories. ... and cotton. Their products feature a wide range of ...
Breaking Medicine News(10 mins):Health News:CRN Named Company Partner of the Year by CT Employment Program 2Health News:Shimadzu’s New LC-MS/MS Provides Superior Speed and Sensitivity for the Utmost in Quantitative Detection and High-Speed Analysis 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 3Health News:PhishLine, LLC Announces New Corporate Headquarters 2
... 2012 Testosterone, the primary male sex hormone, appears ... its effects have remained unclear. Nicole Carrier and Mohamed ... to elucidate these mechanisms. They,ve discovered that a ... in memory formation and regulation of stress responses, plays ...
... Society (ERS) and the European Centre for Disease Prevention ... Standards for Tuberculosis Care (ESTC). The 21 patient-centred standards ... ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) ... in the EU/EEA in 2010 clearly showing that TB ...
... in men with prostate cancer before prostatectomy helped to reduce ... cancer, according to the results of a phase II study. ... at the Princess Margaret Hospital, University Health Network in Toronto, ... 2012, held here March 31 - April 4. Metformin ...
... FRIDAY, March 30 (HealthDay News) -- Cold conditions may affect ... research studies, a new study suggests. Researchers from the ... drugs tested on mice that were housed in chilly temperatures ... because being cold triggers changes in mice,s immune function and ...
... FRIDAY, March 30 (HealthDay News) -- While unseasonably warm weather ... thrilled with the early arrival of spring. Arriving along ... hay-fever sufferers sneezing at least a few weeks sooner than ... season starting early, but the pollen counts are breaking records. ...
... , FRIDAY, March 30 (HealthDay News) -- The declining ... a specialty is cause for concern because there,s already ... downward trend has occurred for the past six years, ... Medical schools need to provide more information and training ...
Cached Medicine News:Health News:Exploring the antidepressant effects of testosterone 2Health News:Towards TB elimination: ECDC and ERS introduce new guidelines on tuberculosis care in Europe 2Health News:Metformin appeared to slow prostate cancer growth 2Health News:For Better Mouse Studies, Let Them Nest 2Health News:Warm Weather Triggers Early Allergy Season 2Health News:Warm Weather Triggers Early Allergy Season 3Health News:Fewer U.S. Med Students Choose Psychiatry: Report 2
Inquire...
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
100L...
Medicine Products: